{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:28Z","timestamp":1791639148614,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,8]],"date-time":"2011-01-08T00:00:00Z","timestamp":1294444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00428-010-1032-3","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T11:10:24Z","timestamp":1294398624000},"page":"47-53","source":"Crossref","is-referenced-by-count":41,"title":["Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours"],"prefix":"10.1007","volume":"459","author":[{"given":"C. Christofer","family":"Juhlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00f6\u00f6g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,8]]},"reference":[{"key":"1032_CR1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A et al (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676\u2013680","journal-title":"Nat Genet"},{"key":"1032_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K et al (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657\u2013663","journal-title":"J Med Genet"},{"key":"1032_CR3","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, V\u00e4lim\u00e4ki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722\u20131729","journal-title":"N Engl J Med"},{"key":"1032_CR4","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"MH Tan","year":"2004","unstructured":"Tan MH, Morrison C, Wang P et al (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10:6629\u20136637","journal-title":"Clin Cancer Res"},{"key":"1032_CR5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"Juhlin CC, Villablanca A, Sandelin K et al (2007) Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer 14:501\u2013512","journal-title":"Endocr Relat Cancer"},{"key":"1032_CR6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","volume":"18","author":"K Sandelin","year":"1994","unstructured":"Sandelin K, Tullgren O, Farnebo LO (1994) Clinical course of metastatic parathyroid cancer. World J Surg 18:594\u2013598, discussion 599","journal-title":"World J Surg"},{"key":"1032_CR7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/bjs.5570","volume":"94","author":"G Ippolito","year":"2007","unstructured":"Ippolito G, Palazzo FF, Sebag F et al (2007) Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg 94:566\u2013570","journal-title":"Br J Surg"},{"key":"1032_CR8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O et al (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30:1140\u20131149","journal-title":"Am J Surg Pathol"},{"key":"1032_CR9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin C, Larsson C, Yakoleva T et al (2006) Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 13:509\u2013523","journal-title":"Endocr Relat Cancer"},{"key":"1032_CR10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"GG Fernandez-Ranvier","year":"2009","unstructured":"Fernandez-Ranvier GG, Khanafshar E, Tacha D et al (2009) Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer 115:334\u2013344","journal-title":"Cancer"},{"key":"1032_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A et al (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94:434\u2013441","journal-title":"J Clin Endocrinol Metab"},{"key":"1032_CR12","first-page":"481","volume":"34","author":"CC Juhlin","year":"2009","unstructured":"Juhlin CC, Haglund F, Villablanca A et al (2009) Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas. Int J Oncol 34:481\u2013492","journal-title":"Int J Oncol"},{"key":"1032_CR13","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","volume":"581","author":"MA Hahn","year":"2007","unstructured":"Hahn MA, Marsh DJ (2007) Nucleolar localization of parafibromin is mediated by three nucleolar localization signals. FEBS Lett 581:5070\u20135074","journal-title":"FEBS Lett"},{"key":"1032_CR14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-09-0272","volume":"17","author":"LM Panicker","year":"2010","unstructured":"Panicker LM, Zhang JH, Dagur PK et al (2010) Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome. Endocr Relat Cancer 17:513\u2013524","journal-title":"Endocr Relat Cancer"},{"key":"1032_CR15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","volume":"21","author":"CC Juhlin","year":"2010","unstructured":"Juhlin CC, Nilsson IL, Johansson K et al (2010) Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas. Endocr Pathol 21:166\u2013177","journal-title":"Endocr Pathol"},{"key":"1032_CR16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S1097-2765(03)00431-3","volume":"12","author":"K Itahana","year":"2003","unstructured":"Itahana K, Bhat KP, Jin A et al (2003) Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 12:1151\u20131164","journal-title":"Mol Cell"},{"key":"1032_CR17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature06255","volume":"450","author":"D Frescas","year":"2007","unstructured":"Frescas D, Guardavaccaro D, Bassermann F et al (2007) JHDM1B\/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 450:309\u2013313","journal-title":"Nature"},{"key":"1032_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2353\/ajpath.2008.070752","volume":"173","author":"L Montanaro","year":"2008","unstructured":"Montanaro L, Trer\u00e9 D, Derenzini M (2008) Nucleolus, ribosomes, and cancer. Am J Pathol 173:301\u2013310","journal-title":"Am J Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-1032-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-010-1032-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-1032-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:35:59Z","timestamp":1559079359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-010-1032-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,8]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s00428-010-1032-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,8]]}}}